Precision Prostate Consulting, LLC announces its rebrand to DeepView Imaging, reflecting the company's mission to provide patients with direct, on-demand access to AI-powered prostate MRI analysis.
Investigators developed and validated new PSMA-PET-based nomograms for prognostication across prostate cancer stages to help ...
The study published by Bastiaan M Privé and colleagues in The Lancet Oncology represents, to our knowledge, the first randomised phase 2 trial evaluating lutetium-177–PSMA-617 (177Lu-PSMA-617) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results